JCI vs RIGL · P/E 44, rev $23.60B vs P/E 9.1, rev $137.5M
Johnson Controls International PLC (JCI) versus Rigel Pharmaceuticals Inc (RIGL) — a side-by-side from cached financials, not a winner call.
Johnson Controls International PLC (JCI) is a building products & equipment company listed on NYSE.
Rigel Pharmaceuticals Inc (RIGL) is a biotechnology company listed on US.
Latest reported JCI revenue for 2025-09-30 was $23.60B. Net income was $3.51B. JCI currently screens at market cap $87.62B and trailing P/E 43.9.
Latest reported RIGL revenue for 2026-06-30 was $137.5M. Net income was $25.9M. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
JCI currently screens at market cap $87.62B and trailing P/E 43.9. RIGL currently screens at market cap $338.3M and trailing P/E 9.1.
Not investment advice. Open the JCI and RIGL stock pages for the full models.
Not investment advice.